pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
Companies
by activity
Most Active
Biggest Pipelines
Recently Active
hiring
Companies Hiring Now
Big Pharma Roles
All Companies →
Drugs & Pipeline
intelligence
Drugs
Patent Cliff
research
Publications
Topics
Calendar
window
Next 90 Days
All (incl. Past)
by type
PDUFAs
Approvals
Earnings
Readouts
◐
Sign In
Subscribe
🐶
home
jobs
news
cal
search
the cabinet
Drugs
8,127
products tracked ·
1,561
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
LXP-109
Non-Small Cell Lung Cancer
LaunXP Biomedical Co Ltd
0
catalysts
Phase 2
LXP-5268
Triple-Negative Breast Cancer (TNBC)
LaunXP Biomedical Co Ltd
0
catalysts
Phase 2
LYGLIV-0001
Liver Diseases
LyGenesis Inc
0
catalysts
Phase 2
LYT-200
Liver Cancer
Gallop Oncology Inc
← prev
page 18 of 53
next →
131
Pain
89
Neurology
1
0
catalysts
Phase 2
Lyophilized Microbiota
Mutational Disorders
Gut-Brain Axis Therapeutics LLC
0
catalysts
Phase 2
M-032
Anaplastic Astrocytoma
UAB Minority Health and Health Equity Research Center
0
catalysts
Phase 2
MAI-001
Depression
Nanjing Mainowei Pharmaceutical Technology Co Ltd.
0
catalysts
Phase 2
MANP
Resistant Hypertension
E-Star BioTech LLC
0
catalysts
Phase 2
MB-105
Cutaneous T-Cell Lymphoma
March Biosciences
0
catalysts
Phase 2
MC-001
Spinal Cord Injury
StemCyte Inc
0
catalysts
Phase 2
MC-232
Hidradenitis Suppurativa
MC2 Therapeutics AS
0
catalysts
Phase 2
MDI-1228
Diabetic Foot Ulcers
Henan Maiyingnuo Pharmaceutical Technology Co Ltd
0
catalysts
Phase 2
MDNA-11
Solid Tumor
$MDNAF
Medicenna Therapeutics Corp.
0
catalysts
Phase 2
MDX-1097
Refractory Multiple Myeloma
HaemaLogix Pty Ltd
0
catalysts
Phase 2
MEDI-0457
Oropharyngeal Cancer
$AZN
ASTRAZENECA PLC
0
catalysts
Phase 2
MET-224o
Obesity
Metsera Inc
0
catalysts
Phase 2
MET-233i
Obesity
Metsera Inc
0
catalysts
Phase 2
METHOTREXATE
METHOTREXATE (METHOTREXATE)
Retinitis Pigmentosa (Retinitis)
Dihydrofolate reductase
$ALDX
Aldeyra Therapeutics, Inc.
0
catalysts
Phase 2
MGD-014
Human Immunodeficiency Virus (HIV) Infections (AIDS)
$MGNX
MACROGENICS INC
0
catalysts
Phase 2
MHB-018A
Graves' Ophthalmopathy
Minghui Pharmaceutical (Shanghai) Co Ltd
0
catalysts
Phase 2
MIT-001
Oral Mucositis
MitoImmune Therapeutics Inc
0
catalysts
Phase 2
MIV-711
Osteoarthritis
Medivir AB
0
catalysts
Phase 2
MK-2214
Alzheimer's Disease
$MRK
Merck & Co., Inc.
0
catalysts
Phase 2
MK-3795
Von Hippel-Lindau Syndrome
$MRK
Merck & Co., Inc.
0
catalysts
Phase 2
MK-6194
Ulcerative Colitis
$MRK
Merck & Co., Inc.
0
catalysts
Phase 2
MNV-101
Pearson Syndrome
Minovia Therapeutics Ltd
0
catalysts
Phase 2
MNV-201
Pearson Syndrome
Minovia Therapeutics Ltd
0
catalysts
Phase 2
MORF-057
Crohn's Disease (Regional Enteritis)
Eli Lilly and Co
0
catalysts
Phase 2
MP-0712
Neuroendocrine Tumors
$MOLN
MOLECULAR PARTNERS AG
0
catalysts
Phase 2
MP-101
dimiracetam [INN]
Amyotrophic Lateral Sclerosis
Mitochon Pharmaceuticals Inc
0
catalysts
